ArticleAntimicrobial agents and chemotherapy2011
Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli.
Article in Antimicrobial agents and chemotherapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Sharing ofmBio · 2025Article
- Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression.Journal of translational medicine · 2023Review
- Antibiotic Resistance in Bacteria-A Review.Antibiotics (Basel, Switzerland) · 2022Review
- Antimicrobial Resistance Profiles and Macrolide Resistance Mechanisms ofMicroorganisms · 2021Article
- Prediction of antimicrobial resistance in clinical Campylobacter jejuni isolates from whole-genome sequencing data.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021Article
- The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC ProgressionFrontiers in oncology · 2021Article
- Antimicrobial resistance in enteric bacteria: current state and next-generation solutions.Gut microbes · 2020Review
- Antibiotic Resistance Profiles and Molecular Mechanisms ofFrontiers in microbiology · 2020Article
- WGS-Based Prediction and Analysis of Antimicrobial Resistance inFrontiers in cellular and infection microbiology · 2020Article
- Molecular Basis of Macrolide Resistance inBioMed research international · 2018Article
- [Gastrointestinal infections].Der Internist · 2017Review
- Macrolide resistance mechanisms and virulence factors in erythromycin-resistant Campylobacter species isolated from chicken and swine feces and carcasses.The Journal of veterinary medical science · 2017Article
- Large Sequence Diversity within the Biosynthesis Locus and Common Biochemical Features of Campylobacter coli Lipooligosaccharides.Journal of bacteriology · 2016Article
- [Drug therapy of infectious diarrhea: part 1: acute diarrhea].Der Internist · 2013Review
- Resistance mechanisms in Campylobacter jejuni.Virulence · 2013Review
- Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.Antimicrobial agents and chemotherapy · 2013Article
- Down-regulation of ribosomal protein L22 in non-small cell lung cancer.Medical oncology (Northwood, London, England) · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to examine macrolide resistance mutations in Campylobacter species. In 76 strains studied, point mutation A to G at position 2059 of the 23S rRNA gene was detected in 30 of the 33 erythromycin-resistant strains. An amino acid insertion in the ribosomal protein L22 was found in one resistant strain without a 23S rRNA mutation. The A2059G mutation is the main cause of macrolide resistance in Campylobacter species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.